Table 2.

Neurologic characteristics of 30 patients affected by Parkinson’s disease with OAB, treated with oral mirabegron, 50 mg/day.

Sex	Age (years) (mean ± SD)	Disease duration (years) (mean ± SD)	Hoen &Yahr score (mean ± SD)	UPDRS score (mean ± SD)	MOCA score (mean ± SD)	MMSE score (mean ± SD)
F = 19	73.4 ± 8.9	7.6 ± 3.9	2.7 ± 0.8	30.5 ± 13	22.5 ± 5.3	25.5 ± 4.6
M = 11	67.3 ± 9.6	8.8 ± 4.5	2.3 ± 1.1	27.3 ± 10	23.3 ± 3.2	23.2 ± 3.2

F, female; M, male; MMSE, Mini Mental State examination; MOCA, Montreal Cognitive Assessment; OAB, overactive bladder; SD, standard deviation; UPDRS, Unified Parkinson’s Disease Rating Scale.